Eli Lilly on Morning Brew Daily

Morning Brew DailyAugust 7, 2026

BofA is spending big on GLP-1’s and AI invents a virus not found in nature for the first time

0:55
mid-roll
Neal Freyman, Toby Howell
Speaker
Morning Brew
August 7, 2026
Announcer-readDirect responseDynamic insertionHealth & Wellness
0:00 / 0:55
@ 16:00 in ep

Transcript

I have eczema, so I get how it can steal your time. But why let eczema take over when you can talk to your doctor about Ebglis? Ebglis Lubrikizumab LBKZ, a 250 milligram per two milliliter injection, is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema, also called atopic dermatitis, that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. Ebglis can be used with or without topical corticosteroids. Don't use if you are allergic to Ebglis. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with Ebglis. Before starting Ebglis, tell your doctor if you have a parasitic infection. Paid partnership with Lilly. Respect your time. Ask your doctor about Ebglis and visit Ebglis.com or call 1-800-LILLY-RX or 1-800-545-5979.

Auto-transcribed · verbatim audio matches · Report an error

Estimated ad cost

~$240range $36$1,700

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →

Episode

Morning Brew Daily
BofA is spending big on GLP-1’s and AI invents a virus not found in nature for the first time
Hosts: Neal Freyman, Toby Howell
Publisher: Morning Brew